Trial Profile
Micardis / MicardisPlus Monitoring of Morning Hypertension and Metabolism II
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary)
- Indications Hypertension in diabetes
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 24 Sep 2014 New trial record